ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 452 filers reported holding ASTRAZENECA PLC in Q4 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $13,548,000 | -16.9% | 495,960 | 0.0% | 0.09% | -11.0% |
Q3 2016 | $16,296,000 | +10.7% | 495,960 | +1.7% | 0.10% | +12.4% |
Q2 2016 | $14,725,000 | +7.2% | 487,770 | 0.0% | 0.09% | +11.2% |
Q1 2016 | $13,735,000 | -12.0% | 487,770 | +6.1% | 0.08% | -12.1% |
Q4 2015 | $15,610,000 | -46.2% | 459,840 | -32.7% | 0.09% | +30.0% |
Q3 2015 | $29,017,000 | +99.9% | 683,610 | +200.0% | 0.07% | +11.1% |
Q2 2015 | $14,517,000 | -6.9% | 227,870 | 0.0% | 0.06% | -14.9% |
Q1 2015 | $15,592,000 | -2.8% | 227,870 | 0.0% | 0.07% | +4.2% |
Q4 2014 | $16,036,000 | -29.2% | 227,870 | -28.2% | 0.07% | -24.5% |
Q3 2014 | $22,658,000 | -1.3% | 317,180 | +2.6% | 0.09% | +5.6% |
Q2 2014 | $22,963,000 | -23.0% | 309,030 | -32.8% | 0.09% | -27.6% |
Q1 2014 | $29,815,000 | +2.3% | 459,569 | -6.4% | 0.12% | -6.8% |
Q4 2013 | $29,141,000 | +10.3% | 490,878 | -3.5% | 0.13% | +6.5% |
Q3 2013 | $26,427,000 | +9.2% | 508,945 | -0.5% | 0.12% | -3.9% |
Q2 2013 | $24,201,000 | – | 511,667 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |